Team - nanovision

Our Team

The Nanovision team includes world-renowned scientists, engineers, surgeons, researchers, and entrepreneurs.

Our Team

The Nanovision team includes world-renowned scientists, engineers, surgeons, researchers, and entrepreneurs.

Scott Thorogood

Chairman and Co-founder

Scott Thorogood is a serial CEO and entrepreneur with over 25 years of international senior management and turnaround experience, focused on life sciences, software, cybersecurity and other technology initiatives.

William Freeman, MD

Medical Advisor and Co-founder

William R. Freeman, M.D. is a Distinguished Professor of Ophthalmology, Director of the UCSD Jacobs Retina Center and Vice Chairman of the Department of Ophthalmology UCSD Shiley Eye Institute.

Paul Citron, MSEE, Ph.D. (hon.)

Board of Directors Observer

Paul Citron retired in 2003 from Medtronic, Inc., a pioneer in the medical device industry and the largest developer of implantable therapeutic devices. He was Vice President of Technology Policy and Academic Relations.

Samuel A. Hardage

Board of Directors

Samuel A. Hardage is the Chairman of San Diego-based The Hardage Group, (THG), which currently owns and operates hotels in multiple states.

Ted Roth

Board of Directors

Ted Roth has over 30 years of investment and management experience in a range of industries from venture technology to established natural resource and industrial companies.

Larry Murrill

CFO

Larry is the managing partner of Murrill/Gerbino, LLP, a San Diego based CPA firm specializing in the needs of emerging businesses and their owners.

Jeff Higgins

Outside General Counsel and Managing General Partner of Gunderson Dettmer

Jeff is a founding partner of the Gunderson Dettmer San Diego and Los Angeles office.

Hiren D. Thacker, PhD

Senior Engineering Advisor

Dr. Hiren D. Thacker advises technology pathfinding and development for retinal prosthesis and low light image sensors at Nanovision.

Our Advisory Board:

Our Advisory Board

Shu Chien, MD, PhD

Paul Citron

Gert Cauwenberghs, PhD

Yuh-Hwa Lo, PhD

Mike Sailor, PhD

The Honorable Jay M. Cohen

Our technology is singularly unique in how the sub retinal device tailors the electrical neural stimulation parameters to the individual patient. It is the most advanced technology available capable of achieving such a degree of patient specificity.

Ready to learn more?

We are the first group to show that an optoelectronic nanowire technology can successfully achieve photoelectronic stimulation of the retina and retinal tissues.